Figure 3From: Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review Comparison of the effects of LMWHs and vitamin K anatomists on survival (time to event analysis) in patients with cancer and venous thromboembolism. Back to article page